John Kelly
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
John Kelly
Founder, Managing Director, Chief Executive / Atomo Diagnostics
For over 20 years, John Kelly was into developing and commercialising medical devices to enhance usability and performance, having started with CR Bard in Europe developing Class III implantable cardiology products.
Prior to co-founding Atomo in September 2009, Mr Kelly acted as the chief operating officer of Unilife Corporation which was previously an ASX-listed company and subsequent to his departure, a Nasdaq-listed company. At Unilife Corporation, he led the global operations team from 2005 to 2008, developing 'Unifill'. Prior to Unilife in 2005, Mr Kelly spent five years at ResMed where he led the new product implementation group and managed the development of Mirage Swift & Activa mask systems.
Prior to co-founding Atomo in September 2009, Mr Kelly acted as the chief operating officer of Unilife Corporation which was previously an ASX-listed company and subsequent to his departure, a Nasdaq-listed company. At Unilife Corporation, he led the global operations team from 2005 to 2008, developing 'Unifill'. Prior to Unilife in 2005, Mr Kelly spent five years at ResMed where he led the new product implementation group and managed the development of Mirage Swift & Activa mask systems.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 206th | Alligator Energy | 51% | 71% |
| 656th | Linius Technologies | 1% | -42% |
| 1257th | Mediland Pharm | -36% | -15% |
| 1328th | Atomo Diagnostics | -40% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 885th |  | Atomo Diagnostics | $3.6m |
| 1036th | | Mediland Pharm | $662k |
| 1037th | | Alligator Energy | $632k |
| 1041st | | Linius Technologies | $558k |
| 1044th | | Tymlez Group | $550k |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Founder, Managing Director, Chief Executive, Atomo Diagnostics | 03 Nov 2020 |
